Key facts
- It has raised $4.3M; the latest was Later Stage VC ($1.4M) in Jan 2025.
- Notable investors include Plum Ventures, Anji Liangshan Investment, Hongfeng Capital, MaiZun Capital, Zhenxiang Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for C.D Intelligence
- ·The full record, as it builds
Funding rounds
No funding rounds for C.D Intelligence are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About C.D Intelligence
Developer of a rehabilitation management system designed for cancer patients. The company's systems provide patients with full rehabilitation services and physicians with a data management platform, committing to improving patients' life quality and extending their lives by integrating traditional medical care with artificial intelligence and big data technologies.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2017
- Website
- chudongsh.com/
- Ownership
- Privately Held (backing)
C.D Intelligence doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in C.D Intelligence shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on C.D Intelligence in its N-PORT filings yet. We sweep new filings monthly.